TY - JOUR
T1 - Effects of adrenomedullin and calcitonin gene-related peptide on airway and pulmonary vascular smooth muscle in guinea-pigs
AU - Pinto, Arthur
AU - Sekizawa, Kiyohisa
AU - Yamaya, Mutsuo
AU - Ohrui, Takashi
AU - Jia, Yu Xia
AU - Sasaki, Hidetada
PY - 1996
Y1 - 1996
N2 - 1. The airway and pulmonary vascular effects of adrenomedullin were studied in the guinea-pig isolated trachea, main bronchi and pulmonary artery in vitro and compared to the effects of calcitonin gene-related peptide (CGRP). 2. In tracheal rings, CGRP (1 nM to 1 μM) potentiated the cholinergic contractions induced by electrical field stimulation (EFS) at 5 Hz in a concentration-dependent manner. At a concentration of 1 μM, CGRP slightly decreased the responses to log EFS frequency, producing 50% of the maximum contraction from a control value of 0.77 ± 0.10 Hz to 0.54 ± 0.05 Hz without a significant effect on the concentration-response curves to acetylcholine (ACh). In contrast, adrenomedullin (1 nM to 1 μM) did not alter either EFS-induced cholinergic or ACh-induced contractions. 3. In bronchial strips, CGRP (1 nM to 1 μM) slightly reduced both the non-adrenergic non-cholinergic (NANC) contraction induced by EFS at 10 Hz and the substance P (1 μM)-induced contraction in a concentration-dependent manner, whereas adrenomedullin (1 μM to 1 μM) was without effect. 4. Neither CGRP (1 μM) nor adrenomedullin (1 μM) altered NANC relaxation induced by EFS at 5 Hz in tracheal rings precontracted with histamine (10 μM). 5. Adrenomedullin (1 nM to 1 μM) and CGRP (1 nM to 1 μM) induced a concentration-dependent relaxation of the histamine (10 μM)- and prostaglandin F(2α) (10 μM)-precontracted pulmonary arterial rings with intact endothelium with a similar potency. 6. Neither removal of the endothelium nor N(G)-nitro-L-arginine methyl ester (100 μM) altered the vasorelaxant effects of adrenomedullin (1 nM to 1 μM) and CGRP (1 nM to 1 μM). 7. The putative CGRP receptor antagonist, CGRP8-37 (1 μM to 10 μM) concentration-dependently attenuated the CGRP (3 nM to 30 nM)-induced vasorelaxant actions, whereas it had no effect on the relaxation of vessel rings induced by adrenomedullin (3 nM to 30 nM). 8. These results suggest that adrenomedullin is a potent vasodilator of the pulmonary artery without any bronchomotor effect in the guinea-pig lung, and that the vasorelaxant actions of adrenomedullin are not mediated via the activation of CGRP(I) receptors.
AB - 1. The airway and pulmonary vascular effects of adrenomedullin were studied in the guinea-pig isolated trachea, main bronchi and pulmonary artery in vitro and compared to the effects of calcitonin gene-related peptide (CGRP). 2. In tracheal rings, CGRP (1 nM to 1 μM) potentiated the cholinergic contractions induced by electrical field stimulation (EFS) at 5 Hz in a concentration-dependent manner. At a concentration of 1 μM, CGRP slightly decreased the responses to log EFS frequency, producing 50% of the maximum contraction from a control value of 0.77 ± 0.10 Hz to 0.54 ± 0.05 Hz without a significant effect on the concentration-response curves to acetylcholine (ACh). In contrast, adrenomedullin (1 nM to 1 μM) did not alter either EFS-induced cholinergic or ACh-induced contractions. 3. In bronchial strips, CGRP (1 nM to 1 μM) slightly reduced both the non-adrenergic non-cholinergic (NANC) contraction induced by EFS at 10 Hz and the substance P (1 μM)-induced contraction in a concentration-dependent manner, whereas adrenomedullin (1 μM to 1 μM) was without effect. 4. Neither CGRP (1 μM) nor adrenomedullin (1 μM) altered NANC relaxation induced by EFS at 5 Hz in tracheal rings precontracted with histamine (10 μM). 5. Adrenomedullin (1 nM to 1 μM) and CGRP (1 nM to 1 μM) induced a concentration-dependent relaxation of the histamine (10 μM)- and prostaglandin F(2α) (10 μM)-precontracted pulmonary arterial rings with intact endothelium with a similar potency. 6. Neither removal of the endothelium nor N(G)-nitro-L-arginine methyl ester (100 μM) altered the vasorelaxant effects of adrenomedullin (1 nM to 1 μM) and CGRP (1 nM to 1 μM). 7. The putative CGRP receptor antagonist, CGRP8-37 (1 μM to 10 μM) concentration-dependently attenuated the CGRP (3 nM to 30 nM)-induced vasorelaxant actions, whereas it had no effect on the relaxation of vessel rings induced by adrenomedullin (3 nM to 30 nM). 8. These results suggest that adrenomedullin is a potent vasodilator of the pulmonary artery without any bronchomotor effect in the guinea-pig lung, and that the vasorelaxant actions of adrenomedullin are not mediated via the activation of CGRP(I) receptors.
UR - http://www.scopus.com/inward/record.url?scp=0029801117&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0029801117&partnerID=8YFLogxK
U2 - 10.1111/j.1476-5381.1996.tb16061.x
DO - 10.1111/j.1476-5381.1996.tb16061.x
M3 - Article
C2 - 8968558
AN - SCOPUS:0029801117
SN - 0007-1188
VL - 119
SP - 1477
EP - 1483
JO - British Journal of Pharmacology
JF - British Journal of Pharmacology
IS - 7
ER -